SCHEMBL24936735

SCHEMBL24936735

c1ccc2c(c1)oc1cccc(-c3ccc(-c4ccc(-n5c6ccccc6c6ccc7oc8ccccc8c7c65)cc4)cc3)c12

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
BACE1 P56817 1/20 0.35
DUSP3 P51452 2/20 0.33
MAPK14 Q16539 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
PTPN5 P54829 1/20 0.32
KMT2A Q03164 1/20 0.32
PTPN11 Q06124 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HDAC4 P56524 1/20 0.32
ALOX5 P09917 1/20 0.31
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24676179 0.92 KDM4E (0.41) L3MBTL1KDM4EATMDUSP3SMN1; SMN2
SCHEMBL24676321 0.92 KDM4E (0.41) L3MBTL1KDM4EATMDUSP3SMN1; SMN2
SCHEMBL17245370 0.91 KDM4E (0.42) L3MBTL1KDM4EATMBACE1DUSP3
SCHEMBL24675414 0.91 KDM4E (0.43) L3MBTL1KDM4EATMDUSP3SMN1; SMN2
SCHEMBL24174744 0.91 KDM4E (0.43) L3MBTL1KDM4EATMDUSP3SMN1; SMN2
SCHEMBL24923248 0.91 ALOX5 (0.43) L3MBTL1KDM4EATMDUSP3ALOX5
SCHEMBL19729770 0.90 L3MBTL1 (0.36) L3MBTL1KDM4EATMDUSP3MAPK14
SCHEMBL24811907 0.90 KDM4E (0.41) L3MBTL1KDM4EATMBACE1DUSP3
SCHEMBL25775321 0.90 KDM4E (0.37) L3MBTL1KDM4EATMBACE1DUSP3
SCHEMBL24173863 0.90 KDM4E (0.44) L3MBTL1KDM4EATMBACE1DUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027888-A1 ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027888-A1 ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND HTR1D, EHD1, HTR3D L3MBTL1 1030/4885KDM4E 3361/4885ATM 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.